Literature DB >> 10756188

DNA strand transfer catalyzed by vaccinia topoisomerase: ligation of DNAs containing a 3' mononucleotide overhang.

C Cheng1, S Shuman.   

Abstract

The specificity of vaccinia topoisomerase for transesterification to DNA at the sequence 5'-CCCTT and its versatility in strand transfer have illuminated the recombinogenic properties of type IB topoisomerases and spawned topoisomerase-based strategies for DNA cloning. Here we characterize a pathway of topoisomerase-mediated DNA ligation in which enzyme bound covalently to a CCCTT end with an unpaired +1T nucleotide rapidly and efficiently joins the CCCTT strand to a duplex DNA containing a 3' A overhang. The joining reaction occurs with high efficiency, albeit slowly, to duplex DNAs containing 3' G, T or C overhangs. Strand transfer can be restricted to the correctly paired 3' A overhang by including 0.5 M NaCl in the ligation reaction mixture. The effects of base mismatches and increased ionic strength on the rates of 3' overhang ligation provide a quantitative picture of the relative contributions of +1 T:A base pairing and electrostatic interactions downstream of the scissile phosphate to the productive binding of an unlinked acceptor DNA to the active site. The results clarify the biochemistry underlying topoisomerase-cloning of PCR products with non-templated 3' overhangs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10756188      PMCID: PMC103307          DOI: 10.1093/nar/28.9.1893

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  18 in total

1.  Two classes of DNA end-joining reactions catalyzed by vaccinia topoisomerase I.

Authors:  S Shuman
Journal:  J Biol Chem       Date:  1992-08-25       Impact factor: 5.157

2.  Site-specific interaction of vaccinia virus topoisomerase I with duplex DNA. Minimal DNA substrate for strand cleavage in vitro.

Authors:  S Shuman
Journal:  J Biol Chem       Date:  1991-06-15       Impact factor: 5.157

3.  Crystal structures of human topoisomerase I in covalent and noncovalent complexes with DNA.

Authors:  M R Redinbo; L Stewart; P Kuhn; J J Champoux; W G Hol
Journal:  Science       Date:  1998-03-06       Impact factor: 47.728

4.  New technique for uncoupling the cleavage and religation reactions of eukaryotic topoisomerase I. The mode of action of camptothecin at a specific recognition site.

Authors:  J Q Svejstrup; K Christiansen; I I Gromova; A H Andersen; O Westergaard
Journal:  J Mol Biol       Date:  1991-12-05       Impact factor: 5.469

5.  Novel non-templated nucleotide addition reactions catalyzed by procaryotic and eucaryotic DNA polymerases.

Authors:  J M Clark
Journal:  Nucleic Acids Res       Date:  1988-10-25       Impact factor: 16.971

6.  Novel approach to molecular cloning and polynucleotide synthesis using vaccinia DNA topoisomerase.

Authors:  S Shuman
Journal:  J Biol Chem       Date:  1994-12-23       Impact factor: 5.157

7.  Specific DNA cleavage and binding by vaccinia virus DNA topoisomerase I.

Authors:  S Shuman; J Prescott
Journal:  J Biol Chem       Date:  1990-10-15       Impact factor: 5.157

8.  Site-specific DNA transesterification by vaccinia topoisomerase: role of specific phosphates and nucleosides.

Authors:  C Cheng; S Shuman
Journal:  Biochemistry       Date:  1999-12-14       Impact factor: 3.162

9.  Mutational analysis of 39 residues of vaccinia DNA topoisomerase identifies Lys-220, Arg-223, and Asn-228 as important for covalent catalysis.

Authors:  C Cheng; L K Wang; J Sekiguchi; S Shuman
Journal:  J Biol Chem       Date:  1997-03-28       Impact factor: 5.157

10.  DNA strand transfer reactions catalyzed by vaccinia topoisomerase I.

Authors:  S Shuman
Journal:  J Biol Chem       Date:  1992-04-25       Impact factor: 5.157

View more
  1 in total

1.  A universal cloning vector using vaccinia topoisomerase I.

Authors:  Liang Geng; Wen Xin; Da-Wei Huang; Gui Feng
Journal:  Mol Biotechnol       Date:  2006-05       Impact factor: 2.695

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.